Clinical Research, Pharma & Healthcare FinancingBelite Bio Reports Preliminary FY2025 Financial ResultsGlobeNewswireMarch 9, 2026March 11, 2026 by GlobeNewswireMarch 9, 2026March 11, 2026014 Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that...